Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Early diagnosis and quick treatment improve life quality for FFA patients.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

FFA's causes may include environmental triggers and genetic factors.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Woman has discoid lupus, frontal fibrosing, and androgenetic alopecia.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Frontal Fibrosing Alopecia might be an autoimmune disease.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.